Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution
Jamie C. Stanford, Christian Young, Donna Hicks, Philip Owens, Andrew Williams, David B. Vaught, Meghan M. Morrison, Jiyeon Lim, Michelle Williams, Dana M. Brantley-Sieders, Justin M. Balko, Debra Tonetti, H. Shelton Earp III, Rebecca S. Cook
Jamie C. Stanford, Christian Young, Donna Hicks, Philip Owens, Andrew Williams, David B. Vaught, Meghan M. Morrison, Jiyeon Lim, Michelle Williams, Dana M. Brantley-Sieders, Justin M. Balko, Debra Tonetti, H. Shelton Earp III, Rebecca S. Cook
View: Text | PDF
Research Article Oncology

Efferocytosis produces a prometastatic landscape during postpartum mammary gland involution

  • Text
  • PDF
Abstract

Breast cancers that occur in women 2–5 years postpartum are more frequently diagnosed at metastatic stages and correlate with poorer outcomes compared with breast cancers diagnosed in young, premenopausal women. The molecular mechanisms underlying the malignant severity associated with postpartum breast cancers (ppBCs) are unclear but relate to stromal wound-healing events during postpartum involution, a dynamic process characterized by widespread cell death in milk-producing mammary epithelial cells (MECs). Using both spontaneous and allografted mammary tumors in fully immune–competent mice, we discovered that postpartum involution increases mammary tumor metastasis. Cell death was widespread, not only occurring in MECs but also in tumor epithelium. Dying tumor cells were cleared through receptor tyrosine kinase MerTK–dependent efferocytosis, which robustly induced the transcription of genes encoding wound-healing cytokines, including IL-4, IL-10, IL-13, and TGF-β. Animals lacking MerTK and animals treated with a MerTK inhibitor exhibited impaired efferocytosis in postpartum tumors, a reduction of M2-like macrophages but no change in total macrophage levels, decreased TGF-β expression, and a reduction of postpartum tumor metastasis that was similar to the metastasis frequencies observed in nulliparous mice. Moreover, TGF-β blockade reduced postpartum tumor metastasis. These data suggest that widespread cell death during postpartum involution triggers efferocytosis-induced wound-healing cytokines in the tumor microenvironment that promote metastatic tumor progression.

Authors

Jamie C. Stanford, Christian Young, Donna Hicks, Philip Owens, Andrew Williams, David B. Vaught, Meghan M. Morrison, Jiyeon Lim, Michelle Williams, Dana M. Brantley-Sieders, Justin M. Balko, Debra Tonetti, H. Shelton Earp III, Rebecca S. Cook

×

Figure 4

Increased expression of Th2-like cytokines in postpartum tumors requires MerTK.

Options: View larger image (or click on image) Download as PowerPoint
Increased expression of Th2-like cytokines in postpartum tumors requires...
(A) A publicly available qRT-PCR dataset of RNA expression levels in normal breast biopsies harvested from premenopausal nulliparous women and premenopausal women 0–2 years after a full-term pregnancy (27) was queried for relative expression levels of the indicated transcripts, which were normalized to dataset housekeeping genes. P values were calculated by Student’s t test. n = 4–20 per group. (B) Cytokine antibody array was performed using lysates from spontaneous MMTV PyVmT tumors harvested from 71-day-old mice (n = 4 tumors per group). Individual cytokine spots are shown from identical exposures. (C) Whole-tumor RNA from 71-day-old virgin and postpartum (Inv d7) mice was assessed by qRT-PCR for Il10, Il4, and Tgfb1. Values are the average relative transcripts levels ± SD. n = 4 tumors analyzed in 6 replicate experiments. *P < 0.05 by Student’s t test. (D) Cytokine antibody array was performed using lysates from MerTK+/+ PyVmT and MerTK–/– PyVmT postpartum tumors (Inv d7). n = 4. (E) Densitometry-based quantitation of relative cytokine levels in whole-tumor lysates. Selected cytokines of interest are shown. Values are the average ± SD. n = 4. P values were calculated by Student’s t test. (F) RNA isolated from whole tumors collected from 71-day-old parous MerTK+/+ PyVmT and MerTK–/– PyVmT mice at Inv d7 was assessed by qRT-PCR to quantify Il10, Il4, and Tgfb1. Values shown are the average ± SD. n = 4. *P < 0.05; ****P < 0.0001 by Student’s t test. (G) RNA isolated from whole tumors from parous mice treated from Inv d0 to Inv d7 with or without BMS-777607 was assessed by qRT-PCR to quantify Il10, Il4, and Tgfb1. Values shown are the average ± SD. n = 4. *P < 0.05; **P < 0.01 by Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts